460 related articles for article (PubMed ID: 17296332)
1. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
[TBL] [Abstract][Full Text] [Related]
3. Targeted drug delivery to mammalian mitochondria in living cells.
Weissig V
Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes.
Yasuzaki Y; Yamada Y; Harashima H
Biochem Biophys Res Commun; 2010 Jun; 397(2):181-6. PubMed ID: 20580633
[TBL] [Abstract][Full Text] [Related]
5. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
Wadia JS; Dowdy SF
Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
[TBL] [Abstract][Full Text] [Related]
7. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial medicine: entering the era of treatment.
Koene S; Smeitink J
J Intern Med; 2009 Feb; 265(2):193-209. PubMed ID: 19192036
[TBL] [Abstract][Full Text] [Related]
9. Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening.
Schwimmer C; Rak M; Lefebvre-Legendre L; Duvezin-Caubet S; Plane G; di Rago JP
Biotechnol J; 2006 Mar; 1(3):270-81. PubMed ID: 16897707
[TBL] [Abstract][Full Text] [Related]
10. Delivery to mitochondria: a narrower approach for broader therapeutics.
Malhi SS; Murthy RS
Expert Opin Drug Deliv; 2012 Aug; 9(8):909-35. PubMed ID: 22663303
[TBL] [Abstract][Full Text] [Related]
11. [Mitochondrial diseases--a new branch of the modern medicine].
Zagoskin PP; Khvatova EM
Vopr Med Khim; 2002; 48(4):321-36. PubMed ID: 12506607
[TBL] [Abstract][Full Text] [Related]
12. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
13. [Mitochondrial syndrome].
Kozłowska I; Rózański J; Ciechanowski K
Pol Merkur Lekarski; 2004 Oct; 17(100):395-8. PubMed ID: 15690713
[TBL] [Abstract][Full Text] [Related]
14. Targeted intracellular delivery of therapeutics: an overview.
Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial diseases: therapeutic approaches.
DiMauro S; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):125-37. PubMed ID: 17486439
[TBL] [Abstract][Full Text] [Related]
16. [Mitochondria in cell life, death and disease].
Wojtczak L; Zabłocki K
Postepy Biochem; 2008; 54(2):129-41. PubMed ID: 18807924
[TBL] [Abstract][Full Text] [Related]
17. Development of targeted delivery systems for nucleic acid drugs.
Mahato RI; Takakura Y; Hashida M
J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
19. Strategies for cytosolic delivery of liposomal macromolecules.
Fretz MM; Mastrobattista E; Koning GA; Jiskoot W; Storm G
Int J Pharm; 2005 Jul; 298(2):305-9. PubMed ID: 15941633
[TBL] [Abstract][Full Text] [Related]
20. Targeting drugs to mitochondria.
Heller A; Brockhoff G; Goepferich A
Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]